
VBIV
Healthcare · Biotechnology · $1.9M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2024
EPS trend, 90 days to now · +31.9% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 15, 2024 | After the close | -0.53 | -0.73 | -37.7% |
| Mar 27, 2024 | Before the open | -0.22 | -0.01 | +95.5% |
| Nov 14, 2023 | After the close | -0.14 | -1.01 | -621.4% |
| Aug 14, 2023 | Before the open | -2.16 | -5.05 | -133.8% |
| May 15, 2023 | Before the open | -1.25 | -3.22 | -157.6% |
| Mar 13, 2023 | Before the open | -0.07 | -0.08 | -14.3% |
| Nov 10, 2022 | Before the open | -0.08 | -0.09 | -12.5% |
| Aug 8, 2022 | Before the open | -0.07 | -0.18 | -157.1% |
| May 9, 2022 | Before the open | -0.08 | -0.08 | 0.0% |
| Mar 7, 2022 | Before the open | -0.07 | -0.07 | 0.0% |
| Nov 8, 2021 | Before the open | -0.07 | -0.06 | +14.3% |
| Aug 2, 2021 | Before the open | -0.06 | -0.07 | -16.7% |
| May 10, 2021 | Before the open | -0.06 |
VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers hepatitis B (HBV) vaccine under the PreHevbrio, PreHevbri, and Sci-B-Vac brand names. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma cancer vaccine…
| -0.07 |
| -16.7% |
| Mar 2, 2021 | Before the open | -0.06 | -0.06 | 0.0% |
| Nov 2, 2020 | Before the open | -0.04 | -0.06 | -50.0% |
| Jul 31, 2020 | Before the open | -0.04 | -0.04 | 0.0% |
| May 6, 2020 | Before the open | -0.06 | -0.05 | +16.7% |
| Mar 5, 2020 | Before the open | -0.06 | -0.02 | +66.7% |
| Nov 6, 2019 | Before the open | -0.13 | -0.15 | -15.4% |
| Aug 9, 2019 | Before the open | -0.14 | -0.13 | +7.1% |
| May 1, 2019 | Before the open | -0.15 | -0.15 | 0.0% |
| Feb 25, 2019 | Before the open | -0.19 | -0.28 | -47.4% |
| Nov 9, 2018 | Before the open | -0.20 | -0.24 | -20.0% |
| Jul 26, 2018 | Before the open | -0.18 | -0.26 | -44.4% |
| May 1, 2018 | Before the open | -0.17 | -0.19 | -11.8% |
| Feb 26, 2018 | After the close | -0.20 | -0.20 | 0.0% |